Immune Cell Cryopreservation Medium Using Albumin and Disaccharides

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Cryopreservation of living cells, particularly immune cells, is challenging due to the harsh conditions imposed by freezing and thawing, leading to low survivability and viability rates.

Innovation Solution

A cryopreservation medium comprising a non-pyrogenic and isotonic crystalloid solution, a disaccharide, a cryoprotectant, and human serum albumin is used to enhance the survivability and viability of immune cells during freezing and thawing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of stationary object

If cells are subjected to freezing and thawing conditions, then cell preservation is achieved, but cell survivability and viability rates are reduced

Engineering Contradiction:
Improvecell preservation durationVSAvoidcell survivability and viability rate
Core Design Contradiction:
Duration of action of stationary objectVSReliability

Solution Approach 1:

The patent modifies the chemical composition parameters of the freezing medium by incorporating specific protective agents (albumin, disaccharides, cryoprotectants) to change the physical-chemical environment during freezing, thereby reducing cellular damage while maintaining preservation duration

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention uses a composite cryopreservation medium containing multiple components (crystalloid solution, albumin, disaccharides, and cryoprotectants) that work synergistically to protect cells during freezing and thawing, resolving the contradiction between preservation duration and cell viability

Inventive Principle:
Principle #40Composite materials

2Stability of the object's composition

If extracellular medium freezes, then osmotic equilibrium is maintained, but intracellular water loss and solute concentration increase occur

Engineering Contradiction:
Improveosmotic equilibriumVSAvoidintracellular freezing and solution effects
Core Design Contradiction:
Stability of the object's compositionVSObject-affected harmful factors

Solution Approach 1:

The patent introduces albumin and disaccharides as intermediary substances that mediate between the extracellular freezing environment and the intracellular space, preventing direct harmful effects of freezing on cell membranes and reducing osmotic stress

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The cryopreservation medium contains pre-added protective agents (cryoprotectants, albumin, disaccharides) that cushion cells against the harmful effects of freezing before intracellular freezing occurs, reducing membrane damage and solute concentration effects

Inventive Principle:
Principle #11Beforehand cushioning (Prior cushioning)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The described cryopreservation medium significantly improves the survivability and viability of immune cells, making it particularly suitable for cryopreserving adoptive cell therapies.

Implementation Method 1

cells subjected to freezing and thawing conditions are exposed to harsh conditions which in turn result in a generally low survivability and/or viability rate. Freezing is destructive to most living cells. Generally, as the extracellular medium freezes, cells attempt to maintain osmotic equilibrium across the membrane leading to intracellular water loss

Methodology Applied
Scientific EffectOsmotic pressure: Osmotic Pressure

Implementation Method 2

a cryopreservation medium described herein comprises a non-pyrogenic and isotonic crystalloid solution, a disaccharide, a cryoprotectant and an albumin

Methodology Applied
Scientific EffectCryoprotection: Cryogenics

Data Source

PatentUS20250031688A1Methods and compositions for cryopreservation of immune cells
Publication Date: 2025.01.30 TAKEDA PHARMA CO LTD
  • US20250031688A1 patent drawing
  • US20250031688A1 patent drawing
  • US20250031688A1 patent drawing

AI summary

The present disclosure provides, among other things, a cryopreservation medium comprising a cryoprotectant, an albumin, a disaccharide and a non-pyrogenic and isotonic crystalloid solution. The disclosure also provides, among other things, a cryopreservation medium for cryopreserving immune cells, the medium comprising: human serum albumin (HSA), sodium chloride, sodium gluconate, sodium acetate trihydrate, potassium chloride, magnesium chloride, dimethyl sulfoxide (DMSO), and a trehalose. The present disclosure also provides, a method of cryopreserving immune cells, transporting and subsequently administering such immune cells to a patient in need thereof.